Hubei Jingjiangyuan Pharmaceutical

Hubei Jingjiangyuan Pharmaceutical is a China-based pharmaceutical company focused on the development, manufacturing, and commercialization of chemical drugs and traditional Chinese medicine (TCM). Established in 2003 and headquartered in Jingzhou, Hubei, the company maintains a diverse portfolio that includes treatments for respiratory, cardiovascular, and metabolic conditions. Its manufacturing facilities are GMP-certified, producing various formulations such as tablets, capsules, and granules. In addition to its own product lines, the company engages in contract manufacturing (CMO) services for domestic and international partners. Jingjiangyuan is recognized as a high-tech enterprise in Hubei province, leveraging both modern chemical synthesis and traditional herbal extraction. The company was listed on the National Equities Exchange and Quotations (NEEQ) in 2016, reflecting its growth in the regional healthcare market.